When talking about Prostate Cancer, a malignant growth of the prostate gland that mainly affects men over 50. Also known as prostatic adenocarcinoma, it can cause urinary issues, bone pain, and fatigue. Early detection is crucial, and the most common screening tool is the PSA test, a blood test that measures prostate‑specific antigen levels. The PSA test influences diagnosis by flagging abnormal spikes that prompt further imaging or biopsy. Understanding this link helps men catch the disease before it spreads.
Once diagnosed, treatment decisions hinge on disease stage, patient age, and overall health. Hormone therapy, often called androgen deprivation therapy (ADT), lowers testosterone to slow tumor growth, and it’s a mainstay for advanced cases. Another pillar is radiation therapy, which uses targeted high‑energy beams to destroy cancer cells while sparing surrounding tissue. Both approaches can be combined with surgery or active surveillance, creating a flexible care plan that matches each patient’s needs. Studies show that using hormone therapy alongside radiation improves survival rates, illustrating how these treatments interconnect.
Risk factors such as family history, a high‑fat diet, and sedentary lifestyle increase the chances of developing prostate cancer, while regular exercise and a balanced diet may reduce risk. Managing these elements, staying informed about PSA trends, and discussing treatment options with a urologist empower men to take control of their health. Below you’ll find a curated set of guides that break down medication comparisons, symptom tracking, and lifestyle tweaks, giving you actionable steps to navigate every stage of prostate cancer care.
Explore the scientific evidence and clinical insights on whether terazosin affects cancer risk, covering studies, mechanisms, patient guidance, and upcoming trials.
Continue reading...